Benitec Biopharma (BNTC) Interest Coverage Ratio (2020 - 2025)
Benitec Biopharma (BNTC) reported Interest Coverage Ratio of 0.9 for Q4 2025, down 86823.06% on a YoY basis from N/an in Q4 2024, and down 159792.44% sequentially from 0.0 in Q3 2025.
Benitec Biopharma (BNTC) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 6 years of Interest Coverage Ratio data on file, last reported at 0.9 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 86823.06% year-over-year to 0.9; the trailing twelve-month figure through Dec 2025 stood at 3.26 (down 129045.89% YoY), and the FY2025 full-year result was 0.01, up 43.7% from the prior year.
- Interest Coverage Ratio slipped to 0.9 in Q4 2025, from 0.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.0 in Q3 2025 to a low of 474.12 in Q1 2021.
- A 5-year average of 31.76 and a median of 1.9 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 99.99% in 2024 and sank 1166407.89% in 2025, its largest moves.
- Tracing BNTC's Interest Coverage Ratio over 5 years: stood at 31.81 in 2021, then jumped by 75.74% to 7.72 in 2022, then soared by 92.04% to 0.61 in 2023, then soared by 99.83% to 0.0 in 2024, then slumped by 86823.06% to 0.9 in 2025.
- Business Quant data shows BNTC's Interest Coverage Ratio at 0.9 in Q4 2025, 0.0 in Q3 2025, and 27.62 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -0.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.90 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -27.62 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.61 |
| Sep 30, 2023 | -17.18 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -2.89 |
| Dec 31, 2022 | -7.72 |
| Sep 30, 2022 | -5.73 |
| Jun 30, 2022 | -0.26 |
| Mar 31, 2022 | -24.71 |
| Dec 31, 2021 | -31.81 |
| Sep 30, 2021 | -21.15 |
| Jun 30, 2021 | -20.08 |
| Mar 31, 2021 | -474.13 |